Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   ATHEROSCLEROSIS

Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome

(2016) Marco Gentile et al.   Biomarkers in Medicine

Combined hyperlipidemia

(2016) Amanda J. Brahm et al.   CURRENT OPINION IN LIPIDOLOGY

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Lomitapide for use in patients with homozygous familial hypercholesterolemia: a narrative review

(2016) Daniela Neef et al.   Expert Review of Clinical Pharmacology

Lipoprotein apheresis

(2015) Patrick M. Moriarty   CURRENT OPINION IN LIPIDOLOGY

Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population

(2015) Maria Donata Di Taranto et al.   MOLECULAR AND CELLULAR PROBES

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

(2015) Jennifer G. Robinson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

(2015) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis

(2015) M.D. Di Taranto et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family

(2014) Anna Ruotolo et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

The genetic architecture of the familial hyperlipidaemia syndromes

(2014) Philippa J. Talmud et al.   CURRENT OPINION IN LIPIDOLOGY

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

(2014) M. Cuchel et al.   EUROPEAN HEART JOURNAL

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic

(2013) Marta Futema et al.   ATHEROSCLEROSIS

The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia

(2013) Gert-Jan R. ten Kate et al.   ATHEROSCLEROSIS

Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

(2011) Paul N. Hopkins et al.   Journal of Clinical Lipidology

An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations

(2011) Maria Romano et al.   JOURNAL OF LIPID RESEARCH

Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy

(2009) Maria Romano et al.   ATHEROSCLEROSIS